Paper41622932
[Research Progress on the Mechanism of Gut Microbiota Influencing Lung Cancer Brain Metastasis via the Brain-gut Axis].
Li D and 7 others. Zhongguo Fei Ai Za Zhi, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. [Research Progress on the Mechanism of Gut Microbiota Influencing Lung Cancer Brain Metastasis via the Brain-gut Axis]. Papers, record 41622932. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41622932
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- [Research Progress on the Mechanism of Gut Microbiota Influencing Lung Cancer Brain Metastasis via the Brain-gut Axis].
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Lung Neoplasms | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Brain | Major topic |
| Humans | |
| Animals |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36831324 | Mechanisms of Blood-Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids. | Cells | 2023 | https://conductscience.org/library/papers/36831324 | PubMed |
| 2 | 39648223 | Chronic Inflammation and Cancer: Key Pathways and Targeted Therapies. | Cancer Invest | 2025 | https://conductscience.org/library/papers/39648223 | PubMed |
| 3 | 24388214 | The role of short-chain fatty acids in health and disease. | Adv Immunol | 2014 | https://conductscience.org/library/papers/24388214 | PubMed |
| 4 | 33418900 | Cancer and Stress: Does It Make a Difference to the Patient When These Two Challenges Collide? | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33418900 | PubMed |
| 5 | 22968153 | Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. | Nat Rev Neurosci | 2012 | https://conductscience.org/library/papers/22968153 | PubMed |
| 6 | 33420630 | Comparative analysis of the tumor immune-microenvironment of primary and brain metastases of non-small-cell lung cancer reveals organ-specific and EGFR mutation-dependent unique immune landscape. | Cancer Immunol Immunother | 2021 | https://conductscience.org/library/papers/33420630 | PubMed |
| 7 | 28853441 | Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity. | Mucosal Immunol | 2018 | https://conductscience.org/library/papers/28853441 | PubMed |
| 8 | 32619934 | Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy. | Curr Opin Pharmacol | 2020 | https://conductscience.org/library/papers/32619934 | PubMed |
| 9 | 40086468 | The intestinal barrier: a pivotal role in health, inflammation, and cancer. | Lancet Gastroenterol Hepatol | 2025 | https://conductscience.org/library/papers/40086468 | PubMed |
| 10 | 35194016 | Targeting polarized phenotype of microglia via IL6/JAK2/STAT3 signaling to reduce NSCLC brain metastasis. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35194016 | PubMed |
| 11 | 35517052 | Enteric Nervous System: The Bridge Between the Gut Microbiota and Neurological Disorders. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/35517052 | PubMed |
| 12 | 38565146 | Intratumor microbiome-derived butyrate promotes lung cancer metastasis. | Cell Rep Med | 2024 | https://conductscience.org/library/papers/38565146 | PubMed |
| 13 | 35482355 | The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review. | JAMA Oncol | 2022 | https://conductscience.org/library/papers/35482355 | PubMed |
| 14 | 41016985 | 5-Hydroxytryptamine promotes non-small cell lung cancer metastasis via the SNRPG/WT1/CDK14 Axis. | Mol Biomed | 2025 | https://conductscience.org/library/papers/41016985 | PubMed |
| 15 | 35203645 | Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling. | Biomedicines | 2022 | https://conductscience.org/library/papers/35203645 | PubMed |
| 16 | 34707612 | Microbiota-Gut-Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics. | Front Immunol | 2021 | https://conductscience.org/library/papers/34707612 | PubMed |
| 17 | 40263747 | Metagenomics and Non-Targeted Metabolomics Reveal the Role of Gut Microbiota and Its Metabolites in Brain Metastasis of Non-Small Cell Lung Cancer. | Thorac Cancer | 2025 | https://conductscience.org/library/papers/40263747 | PubMed |
| 18 | 40802513 | Bifidobacterium animalis suppresses non-small cell lung cancer progression and modulates tumor immunity through indole-3-acetic acid. | Cell Rep | 2025 | https://conductscience.org/library/papers/40802513 | PubMed |
| 19 | 33061482 | The Impact of Gut Microbiota Disorders on the Blood-Brain Barrier. | Infect Drug Resist | 2020 | https://conductscience.org/library/papers/33061482 | PubMed |
| 20 | 28342734 | Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases. | J Autoimmun | 2017 | https://conductscience.org/library/papers/28342734 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41622932
GET https://conductscience.org/api/papers/v1/41622932/references?page=2